Market valued at $1.45B in 2024 grows at 10.4% CAGR driven by biocompatible hemostatic solutions in surgical and trauma ...

According to SNS Insider Research, Hemostasis Products Market Growth is Driven by Rising Surgical Volumes, Trauma Incidence, and Accelerating Demand for Advanced Bleeding Control Technologies.Austin, ...

HemoSonic’s diagnostic device uses ultrasound technology to quickly determine a critical factor in the operating room: hemostasis, the body’s ability to stop bleeding. It’s FDA approved for cardiac ...

New York, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The global hemostasis products market size is estimated to attain at ~5.1% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 1.73 ...

Named among the 250 best inventions of 2024, the Quantra Hemostasis System provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes HemoSonics’ Quantra ...

Fibrin plays a major role in stopping bleeding and healing wounds. However, if fibrin is formed in excess, e.g., in chronic wounds, thrombosis and subsequent vascular occlusions can occur. Therefore, ...

Named among the 250 best inventions of 2024, the Quantra Hemostasis System provides comprehensive blood analysis detailing hemostasis in the operating room in less than 15 minutes DURHAM, ...

PARIS, France—Use of a potassium ferrate hemostatic patch instead of conventional dressings following radial PCI can lead to “substantial” benefits that go beyond trimming the time to hemostasis and ...

The FDA has approved Gelfoam Plus Hemostasis Kit, a combination hemostasis product that contains Pfizer’s Gelfoam Sterile Sponge and Baxter’s Thrombin (Human) dried powder for use in controlling ...

The first and only cartridge-based FDA-cleared viscoelastic testing platform for obstetrics, the Quantra System provides comprehensive blood analysis, delivering rapid, real-time coagulation insights ...